Associate Professor Rebecca McKetin

Tabs

Main

University role:

Associate Professor

Phone:

02 93850331 (Ext x 50294)

Email:

r.mcketin@unsw.edu.au

A/Prof Rebecca McKetin (BSc(Psychol)Hons. PhD) leads a program of research into stimulant use epidemiology and interventions at the National Drug and Alcohol Research Centre, UNSW. Her current research involves the online delivery of psychological help for people who use stimulants (Breaking the Ice) the trialling of new pharmacotherapy options for methamphetamine dependence (the Tina Trial, the N-ICE trial; the LiMA study) and the development of novel responses to methamphetamine use in Aboriginal and Torres Strait Islander communities (NIMAC). Rebecca established the first longitudinal treatment outcomes study for methamphetamine use internationally (the Methamphetamine Treatment Outcomes Study, MATES), a 3-year prospective cohort of 501 people dependent on methamphetamine, demonstrating the impact of community-based treatments for this drug. She has adapted in-direct prevalence estimation methods to estimate the number of dependent methamphetamine users in Australia and has been involved in the development of regional systems to monitor methamphetamine and other drugs in the Asia Pacific. Her work has been pivotal in quantifying the risk of psychosis, violence and other mental health outcomes related to the use of methamphetamine. She is a Senior Editor for Addiction, a consultant to the United Nations, and a member of the Australian Institute of Policy and Science.

Qualifications:

BSc(Psychol) Hons PhD

Grants:

McKetin R, Farrell M, Degenhardt L, Dore G, Shoptaw S, Kelly P, Turner A, Clare P, Arunogiri S, Colledge S. (AIs Berk, Sinclair, Reid, Hill, Hayllar, Goodman, Dean, Christmass, Byrne, Koeijers.) A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine (“Ice”) dependence. 2020 Medical Research Futures Fund Efficient Use of Existing Medicines. Grant no. 2007155. 2021-2025. $4,899,579.86

McKetin R, Farrell M, Degenhardt L, Berk M, Dean O, Dore G, Shoptaw S, Kelly P, Turner A, Clare P. (AIs Arunogiri, Colledge, Sinclair, Reid, Hill, Hayllar, Goodman, Christmass, Byrne, Koeijers.) A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine ("Ice") dependence (APP2000375). NHMRC Clinical Trials and Cohort Studies. $3,923,009.33. (Relinquished)

Berk M et al. Rossell S, Fitzgerald P. O’Neil A, Turner A, Rodgers A, Mihalopoulos C, Ng C, Galletly C, Davey C, Harris A, Pantelis C Loo C, Lubman D., Sisknd D, Forbes D, Meyer D, Jacka F, Malhi G, Murray G. Christensen H, Kulkarni J, Sarris J, McGrath J, Hoy K, Mills K, Nelson M, O’Donnell M, Gunn J, Millard M, Kyrios M, Yuce M, Glozier N, Martin N, Dean O, Almeida O, Batterham P, McKetin R, Bryant R, Osborne R, Harvey S, Hood S, Touyz S, Sundram S, Apostolopoulos V, Zoungas S, Venkatesh S, Russell S. Medical Research Futures Fund. 2020 Million Minds Mission Mental Health Research. Mental Health Australia General Clinical Trial Network (MAGNET). 2022-2027. $11,998,907.

McKetin R, Degenhardt L, Farrell M, Clay S, Sutherland R, Colledge S, Grebely J, Marshall A, Arunogiri S, Ginley M, Nagle J, Christmass M, MacCartney P, Membrey D. Integrating contingency management for methamphetamine use into routine clinical care in Australia. Seed funding National Centre for Clinical Research on Emerging Drugs (NCCRED) Seed Funding Round 4. 2021-2022 $86,109

Ward J, Reilly R, McKetin R, Ezard N, Treloar C, Dunlop A, Wand H Roe Y, Butt J. Quinn B. An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings. National Centre for Clinical Research into Emerging Drugs Seed Funding $68,400

Arunogiri S, Bedi G, McGregor I, Buismanpijlman F, McKetin R, Lubman D, Manning V, Rubenis A. An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women. National Centre for Clinical Research into Emerging Drugs Seed Funding round 3 (application no. NCR3SF18) 2019, $95,604.50

McKetin R, Dean O, Lubman D, Dietze P, Higgs P, Kelly P, Turner A, Quinn B, Carter G. The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence NHMRC Project Grant APP1128147. 2017-2019, $1,551,368

Ward J, McKetin R, Treloar C, Conigrave K, Dunlop A, Wilkes E, Gray D, Quinn B, Wand H, Ezard N. Novel interventions to address methamphetamines in Aboriginal communities, including a randomised trial of a web based therapeutic tool used to treat dependence in clinical settings. NHMRC Project Grant No. 1100696. 2016-2020, $2,177,908

Lintzeris N, Ali R, Dunlop A, Ezard N, White J, McKetin R, Bruno R, Carr A, Dolan K. randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence. NHMRC Project Grant no. 1109466. 2016-2019. $1,327,084

Dore G, Degenhardt L, Lloyd A, Farrell M. (Chief Investigators). Grebely J, Larney S, Larance B, Hickman M, Houghton M, Cox A, Luciani F, Bull R, McKetin R, Dunlop A. (Associate investigators). Improving the health of people with problematic drug use: hepatitis C and drug dependence. Program Grant, 1150078. $9,060,140, 2019-2023.

Berk M, McGrath J, Malhi G, McNeil J, McGorry P, Jacka F, Cotton S, Walder K, Dean O, Williams L. (Chief Investigators). Amminger, McKetin, Hopwood, Ng, Dodd, Venkatesh, Sarris, McGee, Siskind, Turner (Associate Investigators). The CRE for the Development of Innovative Therapies for Psychiatric Disorders. NHMRC CRE 1135112. 2019-2023.

Butterworth P, Anstey K, Cherbuin N, Easteal S, McKetin R, Leach L, Olesen S, Burns R, McNamee P. Mental health and the PATH to Midlife. Project Grant No. APP1081617. 2016-2017, $758,689

Teesson M, Andrews G, Newton N, Slade T. Chapman C Allsop S, Hides L, McBride N. (Chief Investigators) Barrett E, Kay-Lambkin F, McGorry P, McKetin R, Robinson J, Sanderson K. (Associate investigators). Preventing anxiety, depression and substance use in adolescents. NHMRC Targeted Mental Health 1047291. 2011-2016, $1,709,987.

Chalmers J, Bright DA, McKetin R. Drunk, high or sober: How do alcohol and illicit drug prices affect young Australians' plans for Saturday night? ARC linkage grant LP110100263 (Partner organization: Department of Justice and Attorney General, NSW) 2011 – 2012, 2011 $30,667, 2012 $39,929

Copeland J, Norberg M, Hides L, McKetin R. The Ecstasy Check-Up: A multi-site trial of a brief intervention for ecstasy use among regular ecstasy users. National Health and Medical Research Council Project Grant 630570. 2010-2012, $454,725

Darke S, Kaye S, Ross J, McKetin R. Violent crime amongst methamphetamine users. National Drug Law Enforcement Research Fund. 2007-2008, $213,456

McKetin R, Mattick R, Ali R, Ross J, Lubman D. Longitudinal Treatment Outcomes for Methamphetamine Dependence: A Treatment Cohort Study. National Health and Medical Research Council 350974. 2005-2009, $709,500

Dawe S, Kavanagh D, Young R, Saunders J, McKetin R, Teesson M. An empirical investigation of psychosis proneness among amphetamine users: current and predictive validity. National Health and Medical Research Council 326220. 2005-2008, $454,500

McKetin R, Rushby R, Evans N, and Pritchard E, Mattick RP. The emergence of potent forms of methamphetamine in Sydney: Developing our understanding of Australia’s dynamic methamphetamine markets. National Drug Law Enforcement Research Fund. 2003-2006, $270,359

Research

Teaching & Supervision

I am available to supervise:

Yes

Areas of supervision:

Stimulant use; methamphetamine use and harms; methamphetamine psychosis; epidemiology; in-direct prevalence estimation; sentinel surveys of substance use; cohort studies; service coverage and barriers to care.

Publications related to this Person

Books

Book Chapters

Journal articles

Najman JM; Farrington DP; Bor W; Clavarino AM; McGee TR; Scott JG; Williams GM; McKetin R, 2022, 'Do cannabis and amphetamine use in adolescence predict adult life success: a longitudinal study', Addiction Research and Theory, vol. 30, pp. 314 - 322, http://dx.doi.org/10.1080/16066359.2022.2032679

Sanatkar S; Heinsch M; Tickner C; Hunt S; Teesson M; Geddes J; Gilbert J; Pedemont L; McKetin R; Kay-Lambkin F, 2022, 'A systematic literature review and narrative synthesis of effective interventions for family and caregivers of people who use methamphetamine', Substance Abuse, vol. 43, pp. 1190 - 1196, http://dx.doi.org/10.1080/08897077.2022.2074600

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13511

Lee WC; Fang SC; Chen YY; Liu HC; Huang MC; McKetin R, 2021, 'Exploring the mediating role of methamphetamine use in the relationship between adverse childhood experiences and attempted suicide', Addictive Behaviors, vol. 123, pp. 107060 - 107060, http://dx.doi.org/10.1016/j.addbeh.2021.107060

McKETIN R; Quinn B; Higgs P; Berk M; Dean OM; Turner A; Kelly PJ; Lubman DI; Carter G; Baker AL; Manning V; Thomas T; Bathish R; Raftery D; Saunders L; Wrobel A; Meehan A; Sinclair B; Reid D; Arunogiri S; Hill H; Cordaro F; Dietze PM, 2021, 'Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial', Drug and Alcohol Review, vol. 40, pp. 1249 - 1255, http://dx.doi.org/10.1111/dar.13183

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, vol. 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

McKetin R; Chrzanowska A; Man N; Peacock A; Sutherland R; Degenhardt L, 2021, 'Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019', Drug and Alcohol Review, vol. 40, pp. 1281 - 1286, http://dx.doi.org/10.1111/dar.13258

Raftery D; Kelly PJ; Deane FP; Carter G; Dean OM; Lubman DI; Turner A; McKetin R, 2021, 'Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use', Journal of Substance Abuse Treatment, vol. 130, pp. 108473 - 108473, http://dx.doi.org/10.1016/j.jsat.2021.108473

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, vol. 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

McKetin R, 2021, 'Household surveys and the case of the Australian methamphetamine situation', Addiction, vol. 116, pp. 2610 - 2611, http://dx.doi.org/10.1111/add.15480

McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M, 2021, 'N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial', eClinicalMedicine, vol. 38, pp. 101005, http://dx.doi.org/10.1016/j.eclinm.2021.101005

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RMD; Teesson M; Saunders JB, 2021, 'Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: Evidence from a prospective cohort study', British Journal of Psychiatry, vol. 219, pp. 361 - 367, http://dx.doi.org/10.1192/bjp.2019.263

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, vol. 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2021, 'A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use', Psychiatry Research, vol. 298, http://dx.doi.org/10.1016/j.psychres.2021.113760

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2021, 'Corrigendum to ‘Is there a discrete negative symptom dimension in people who use methamphetamine?’Comprehensive Psychiatry 93 (2019) 27–32 (Comprehensive Psychiatry (2019) 93 (27–32), (S0010440X19300252), (10.1016/j.comppsych.2019.06.002))', Comprehensive Psychiatry, http://dx.doi.org/10.1016/j.comppsych.2021.152231

Boden JM; Foulds JA; Newton-Howes G; McKetin R, 2021, 'Methamphetamine use and psychotic symptoms: Findings from a New Zealand longitudinal birth cohort', Psychological Medicine, pp. 1 - 8, http://dx.doi.org/10.1017/S0033291721002415

Raftery D; Kelly PJ; Deane FP; Baker AL; Ingram I; Goh MCW; Lubman DI; Carter G; Turner A; Dean OM; Sinclair BL; McKetin R, 2020, 'Insight in substance use disorder: A systematic review of the literature', Addictive Behaviors, vol. 111, http://dx.doi.org/10.1016/j.addbeh.2020.106549

McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, vol. 216, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262

McKetin R; Voce A; Burns RA; Quinn B, 2020, 'The Short Barriers Questionnaire (SBQ): Validity, factor structure and correlates in an out-of-treatment sample of people dependent on methamphetamine', Journal of Substance Abuse Treatment, vol. 116, http://dx.doi.org/10.1016/j.jsat.2020.108029

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, vol. 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

Cumming C; Kinner SA; McKetin R; Li I; Preen D, 2020, 'Methamphetamine use, health and criminal justice system outcomes: A systematic review', Drug and Alcohol Review, vol. 39, pp. 505 - 518, http://dx.doi.org/10.1111/dar.13062

Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, vol. 23, pp. e25495, http://dx.doi.org/10.1002/jia2.25495

Kelly PJ; Baker AL; Fagan NL; Turner A; Deane F; McKetin R; Callister R; Collins C; Ingram I; Wolstencroft K; Townsend C; Osborne BA; Zimmermann A, 2020, 'Better Health Choices: Feasability and preliminary effectiveness of a peer delivered healthy lifestyle intervention in a community mental health setting', Addictive Behaviors, vol. 103, http://dx.doi.org/10.1016/j.addbeh.2019.106249

Arunogiri S; McKetin R, 2020, 'Comment on Zang et al 2019: The importance of distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use', Addiction Biology, vol. 25, pp. e12776 - e12776, http://dx.doi.org/10.1111/adb.12776

Foulds JA; Boden JM; McKetin R; Newton-Howes G, 2020, 'Methamphetamine use and violence: Findings from a longitudinal birth cohort', Drug and Alcohol Dependence, vol. 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107826

Arunogiri S; McKetin R; Verdejo-Garcia A; Lubman DI, 2020, 'The Methamphetamine-Associated Psychosis Spectrum: a Clinically Focused Review', International Journal of Mental Health and Addiction, vol. 18, pp. 54 - 65, http://dx.doi.org/10.1007/s11469-018-9934-4

Arunogiri S; Verdejo-Garcia A; McKetin R; Rubenis AJ; Fitzpatrick RE; Lubman DI, 2019, 'Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms', Frontiers in Psychiatry, vol. 10, http://dx.doi.org/10.3389/fpsyt.2019.00889

Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R, 2019, 'Responding to global stimulant use: challenges and opportunities', The Lancet, vol. 394, pp. 1652 - 1667, http://dx.doi.org/10.1016/S0140-6736(19)32230-5

McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L, 2019, 'Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis', EClinicalMedicine, vol. 16, pp. 81 - 97, http://dx.doi.org/10.1016/j.eclinm.2019.09.014

Raftery D; Kelly PJ; Deane FP; Mcketin R; Baker AL; Turner A; Dean OM, 2019, 'Measuring cognitive insight in people with problematic substance use: An exploration of the factor validity of the Beck Cognitive Insight Scale', Drug and Alcohol Review, vol. 38, pp. 622 - 629, http://dx.doi.org/10.1111/dar.12966

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2019, 'Is there a discrete negative symptom syndrome in people who use methamphetamine?', Comprehensive Psychiatry, vol. 93, pp. 27 - 32, http://dx.doi.org/10.1016/j.comppsych.2019.06.002

McKetin R; Voce A; Burns R; Shanahan M, 2019, 'Health-related quality of life among people who use methamphetamine', Drug and Alcohol Review, vol. 38, pp. 503 - 509, http://dx.doi.org/10.1111/dar.12934

McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M, 2019, 'A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence', Trials, vol. 20, http://dx.doi.org/10.1186/s13063-019-3450-0

Voce A; Calabria B; Burns R; Castle D; McKetin R, 2019, 'A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis: Substance Use and Misuse', Substance Use and Misuse, vol. 54, pp. 549 - 559, http://dx.doi.org/10.1080/10826084.2018.1521430

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, vol. 21, http://dx.doi.org/10.2196/14084

Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'Quantifying the societal cost of methamphetamine use to Australia', International Journal of Drug Policy, vol. 62, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.08.015

McKetin R; Voce A; Burns R; Ali R; Lubman DI; Baker AL; Castle DJ, 2018, 'Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?', Frontiers in Psychiatry, vol. 9, http://dx.doi.org/10.3389/fpsyt.2018.00578

McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S, 2018, 'First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine', Schizophrenia Research, vol. 199, pp. 456 - 457, http://dx.doi.org/10.1016/j.schres.2018.04.021

McKetin R, 2018, 'Methamphetamine psychosis: insights from the past', Addiction, vol. 113, pp. 1522 - 1527, http://dx.doi.org/10.1111/add.14170

McKetin R; Lubman DI; Baker A; Dawe S; Ross J; Mattick RP; Degenhardt L, 2018, 'The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study', Addiction, vol. 113, pp. 1276 - 1285, http://dx.doi.org/10.1111/add.14181

Voce A; McKetin R; Burns R; Castle D; Calabria B, 2018, 'The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses', Psychiatry Research, vol. 265, pp. 19 - 24, http://dx.doi.org/10.1016/j.psychres.2018.04.015

Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N, 2018, 'LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-020723

Arunogiri S; Foulds JA; McKetin R; Lubman DI, 2018, 'A systematic review of risk factors for methamphetamine-associated psychosis', Australian and New Zealand Journal of Psychiatry, vol. 52, pp. 514 - 529, http://dx.doi.org/10.1177/0004867417748750

McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI, 2018, 'Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact', Drug and Alcohol Review, vol. 37, pp. 196 - 204, http://dx.doi.org/10.1111/dar.12518

McKetin R; Kothe A; Baker AL; Lee NK; Ross J; Lubman DI, 2018, 'Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study', Drug and Alcohol Review, vol. 37, pp. 70 - 78, http://dx.doi.org/10.1111/dar.12528

Howard KA; Griffiths KM; McKetin R; Ma J, 2018, 'Can a brief biologically-based psychoeducational intervention reduce stigma and increase help-seeking intentions for depression in young people? A randomised controlled trial', Journal of Child and Adolescent Mental Health, vol. 30, pp. 27 - 39, http://dx.doi.org/10.2989/17280583.2018.1467323

McKetin R, 2017, 'Why methamphetamine-related deaths need more attention', Addiction, vol. 112, pp. 2203 - 2204, http://dx.doi.org/10.1111/add.14021

Kelly PJ; Robinson LD; Baker AL; Deane FP; McKetin R; Hudson S; Keane C, 2017, 'Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life', Addictive Behaviors, vol. 71, pp. 25 - 30, http://dx.doi.org/10.1016/j.addbeh.2017.02.006

Room R; Dietze P; McKetin R, 2017, 'Gearing up at the Review', Drug and Alcohol Review, vol. 36, pp. 441, http://dx.doi.org/10.1111/dar.12577

McKetin R; Baker AL; Dawe S; Voce A; Lubman DI, 2017, 'Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders', Psychiatry Research, vol. 251, pp. 349 - 354, http://dx.doi.org/10.1016/j.psychres.2017.02.028

McKetin R; Allsop S, 2017, 'When the Evidence is not Enough: Commentary on Härtel-Petri et al', Pharmacopsychiatry, vol. 50, pp. 105 - 106, http://dx.doi.org/10.1055/s-0043-102184

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, vol. 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

McKetin R; Dean OM; Baker AL; Carter G; Turner A; Kelly PJ; Berk M, 2017, 'A potential role for N-acetylcysteine in the management of methamphetamine dependence', Drug and Alcohol Review, vol. 36, pp. 153 - 159, http://dx.doi.org/10.1111/dar.12414

McKetin R; Parasu P; Cherbuin N; Eramudugolla R; Anstey KJ, 2016, 'A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults', Drug and Alcohol Dependence, vol. 169, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2016.10.022

McKetin R; Degenhardt L; Hall WD, 2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002e2014', Medical Journal of Australia, vol. 205, pp. 426, http://dx.doi.org/10.5694/MJA16.01043

Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R, 2016, 'Prescription opioid analgesics for pain management in Australia: 20 years of dispensing', Internal Medicine Journal, vol. 46, pp. 955 - 963, http://dx.doi.org/10.1111/imj.12966

Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R, 2016, 'Prescription opioid analgesics for pain management in Australia: twenty years of dispensing (vol 46, pg 955, 2016)', INTERNAL MEDICINE JOURNAL, vol. 46, pp. 963 - 963, http://dx.doi.org/10.1111/imj.13155

Hemachandra D; McKetin R; Cherbuin N; Anstey KJ, 2016, 'Heavy cannabis users at elevated risk of stroke: Evidence from a general population survey', Australian and New Zealand Journal of Public Health, vol. 40, pp. 226 - 230, http://dx.doi.org/10.1111/1753-6405.12477

McKetin R, 2016, 'Will the Australian Government's response to its 'National Ice Taskforce' deliver more treatment as promised?', Drug and Alcohol Review, vol. 35, pp. 247 - 249, http://dx.doi.org/10.1111/dar.12423

McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI, 2016, 'Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users', Psychiatry Research, vol. 238, pp. 166 - 171, http://dx.doi.org/10.1016/j.psychres.2016.02.038

McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; Young RMCD; Voce A; Saunders JB, 2016, 'The profile of psychiatric symptoms exacerbated by methamphetamine use', Drug and Alcohol Dependence, vol. 161, pp. 104 - 109, http://dx.doi.org/10.1016/j.drugalcdep.2016.01.018

Degenhardt L; Larney S; Chan G; Dobbins T; Weier M; Roxburgh A; Hall WD; McKetin R, 2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', MEDICAL JOURNAL OF AUSTRALIA, vol. 204, http://dx.doi.org/10.5694/mja15.00671

Wakabayashi M; Berecki-Gisolf J; Banwell C; Kelly M; Yiengprugsawan V; McKetin R; Seubsman SA; Iso H; Sleigh A; Chokhanapitak J; Khamman S; Pangsap S; Puengson J; Rimpeekool W; Somboonsook B; Vilainerun D; Pachanee CA; Tangmunkolvorakul A; Tawatsupa B; Somkotra T; Bain C; Banks E; Caldwell B; Carmichael G; Dellora T; Dixon J; Friel S; Harley D; Jordan S; Kjellstrom T; Lim L; McClure R; McMichael A; Strazdins L; Tranh T; Zhao J, 2016, 'Non-fatal injury in Thailand from 2005 to 2013: Incidence trends and links to alcohol consumption patterns in the Thai Cohort Study', Journal of Epidemiology, vol. 26, pp. 471 - 480, http://dx.doi.org/10.2188/jea.JE20150218

Degenhardt L; Larney S; Chan G; Dobbins T; Weier M; Roxburgh A; Hall W; McKetin R, 2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', Medical Journal of Australia, vol. 204, pp. 1.e1 - 1.e6, http://dx.doi.org/10.5694/mja15.00671

Wakabayashi M; McKetin R; Banwell C; Yiengprugsawan V; Kelly M; Seubsman SA; Iso H; Sleigh A; Chokhanapitak J; Khamman S; Pangsap S; Puengson J; Rimpeekool W; Somboonsook B; Vilainerun D; Pachanee CA; Tangmunkolvorakul A; Tawatsupa B; Bain C; Banks E; Berecki-Gisolf J; Caldwell B; Carmichael G; Dellora T; Dixon J; Friel S; Harley D; Jordan S; Kjellstrom T; Lim L; McClure R; McMichael A; Strazdins L; Tranh T; Zhao J, 2015, 'Alcohol consumption patterns in Thailand and their relationship with non-communicable disease', BMC Public Health, vol. 15, http://dx.doi.org/10.1186/s12889-015-2662-9

Ciketic S; Hayatbakhsh R; Mcketin R; Doran CM; Najman JM, 2015, 'Cost-effectiveness of counselling as a treatment option for methamphetamine dependence', Journal of Substance Use, vol. 20, pp. 239 - 246, http://dx.doi.org/10.3109/14659891.2014.900580

McKetin R; Coen A; Kaye S, 2015, 'A comprehensive review of the effects of mixing caffeinated energy drinks with alcohol', Drug and Alcohol Dependence, vol. 151, pp. 15 - 30, http://dx.doi.org/10.1016/j.drugalcdep.2015.01.047

Tait RJ; McKetin R; Kay-Lambkin F; Carron-Arthur B; Bennett A; Bennett K; Christensen H; Griffiths K, 2015, 'Six-month outcomes of a web-based intervention for users of amphetamine-type stimulants: Randomized controlled trial', Journal of Medical Internet Research, vol. 17, pp. e105, http://dx.doi.org/10.2196/jmir.3778

Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RMD; Teesson M; Saunders JB, 2015, 'Primary and substance-induced psychotic disorders in methamphetamine users', Psychiatry Research, vol. 226, pp. 91 - 96, http://dx.doi.org/10.1016/j.psychres.2014.11.077

Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I, 2015, 'Typologies of positive psychotic symptoms in methamphetamine dependence', American Journal on Addictions, vol. 24, pp. 94 - 97, http://dx.doi.org/10.1111/ajad.12160

Norberg MM; Hides L; Olivier J; Khawar L; McKetin R; Copeland J, 2014, 'Brief Interventions to Reduce Ecstasy Use: A Multi-Site Randomized Controlled Trial', Behavior Therapy, vol. 45, pp. 745 - 759, http://dx.doi.org/10.1016/j.beth.2014.05.006

Tait R; McKetin R; Kay-Lambkin F; Carron-Arthur B; Bennett A; Bennett K; Christensen H; Griffiths KM, 2014, 'Breakingtheice: 3 month outcomes of a randomized control trial of a web-based intervention for users of amphetamine-type stimulants', JMIR Mental Health, vol. 1, http://dx.doi.org/10.2196/mental.3278

Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I, 2014, 'Typologies of positive psychotic symptoms in methamphetamine dependence', American Journal on Addictions, http://dx.doi.org/10.1111/j.1521-0391.2014.12160.x

Mcketin R; Livingston M; Chalmers J; Bright D, 2014, 'The role of off-licence outlets in binge drinking: A survey of drinking practices last Saturday night among young adults in Australia', Drug and Alcohol Review, vol. 33, pp. 51 - 58, http://dx.doi.org/10.1111/dar.12073

McKetin R; Copeland J; Norberg MM; Bruno R; Hides L; Khawar L, 2014, 'The effect of the ecstasy 'come-down' on the diagnosis of ecstasy dependence', Drug and Alcohol Dependence, vol. 139, pp. 26 - 32, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.697

Mcketin R; Lubman DI; Najman JM; Dawe S; Butterworth P; Baker AL, 2014, 'Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study', Addiction, vol. 109, pp. 798 - 806, http://dx.doi.org/10.1111/add.12474

Sunderland M; Chalmers J; Mcketin R; Bright D, 2014, 'Typologies of alcohol consumption on a saturday night among young adults', Alcoholism: Clinical and Experimental Research, vol. 38, pp. 1745 - 1752, http://dx.doi.org/10.1111/acer.12400

Mcketin R; Chalmers J; Sunderland M; Bright DA, 2014, 'Recreational drug use and binge drinking: Stimulant but not cannabis intoxication is associated with excessive alcohol consumption', Drug and Alcohol Review, vol. 33, pp. 436 - 445, http://dx.doi.org/10.1111/dar.12147

Mcketin R; Coen A, 2014, 'The Effect of Energy Drinks on the Urge to Drink Alcohol in Young Adults', Alcoholism: Clinical and Experimental Research, vol. 38, pp. 2279 - 2285, http://dx.doi.org/10.1111/acer.12498

Lin PX; Li JH; Chen SH; Chang HC; McKetin R, 2014, 'Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan', Journal of Food and Drug Analysis, vol. 22, pp. 370 - 378, http://dx.doi.org/10.1016/j.jfda.2014.01.017

Dawe S; Gullo MJ; Minge S; McKetin R; Hides L; Kavanagh DJ; Young RMD, 2013, 'An investigation of schizotypy in injecting amphetamine users', Personality and Individual Differences, vol. 55, pp. 508 - 514, http://dx.doi.org/10.1016/j.paid.2013.04.024

Mcketin R; Nielsen S, 2013, 'Online open access: We all want it, but can we afford it?', Drug and Alcohol Review, vol. 32, pp. 447 - 448, http://dx.doi.org/10.1111/dar.12067

Bosanquet D; MacDougall HG; Rogers SJ; Starmer GA; McKetin R; Blaszczynski A; McGregor IS, 2013, 'Driving on ice: Impaired driving skills in current methamphetamine users', Psychopharmacology, vol. 225, pp. 161 - 172, http://dx.doi.org/10.1007/s00213-012-2805-y

McKetin R; Lubman D; Baker A; Dawe S; Ali R, 2013, 'Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study', JAMA Psychiatry, vol. 70, pp. 319 - 324, http://dx.doi.org/10.1001/jamapsychiatry.2013.283

Ciketic S; McKetin R; Doran CM; Najman JM; Veerman JL; Hayatbakhsh RM, 2013, 'Health-related quality of life (HRQL) among methamphetamine users in treatment', Mental Health and Substance Use: Dual Diagnosis, vol. 6, pp. 250 - 261, http://dx.doi.org/10.1080/17523281.2012.713390

McKetin R; Dunlop AJ; Holland RM; Sutherland R; Baker A; Salmon AM; Hudson SL, 2013, 'Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia', Drug and Alcohol Review, vol. 32, pp. 80 - 87, http://dx.doi.org/10.1111/j.1465-3362.2012.00471.x/pdf

Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J, 2013, 'A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes', Drug and Alcohol Review, vol. 32, pp. 88 - 95, http://dx.doi.org/10.1111/j.1465-3362.2012.00473.x/pdf

McKetin R, 2013, 'The brave new world of open access', Drug and Alcohol Review, vol. 32, pp. 1 - 2, http://dx.doi.org/10.1111/dar.12021/pdf

McKetin R; Najman JM; Baker A; Lubman D; Dawe S; Ali R; Lee N; Mattick RP; Mamun A, 2012, 'Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)', Addiction, vol. 107, pp. 1998 - 2008, http://dx.doi.org/10.1111/j.1360-0443.2012.03933.x/full

Tait RJ; McKetin R; Kay-Lambkin F; Bennett K; Tam A; Bennett A; Geddes J; Garrick A; Christensen HM; Griffiths K, 2012, 'Breakingtheice: A protocol for a randomised controlled trial of an internet-based intervention addresing amphetamine-type stimulant use', BMC Psychiatry, vol. 12, pp. 1 - 9, http://dx.doi.org/10.1186/1471-244X-12-67

Pluddemann A; Flisher AJ; McKetin R; Parry CD; Lombard CJ, 2012, 'Methamphetamine use and sexual risk behavior among high school students in Cape Town, South Africa', Journal of Child and Adolescent Substance Abuse, vol. 21, pp. 181 - 191, http://dx.doi.org/10.1080/1067828X.2012.662437

Ciketic S; Hayatbakhsh MR; Doran CM; Najman JM; McKetin R, 2012, 'A review of psychological and pharmacological treatment options for methamphetamine dependence', Journal of Substance Use, vol. 17, pp. 363 - 383, http://dx.doi.org/10.3109/14659891.2011.592900

McKetin R, 2012, 'Increasing alcohol use disorders among mid-life Australians: Time for a new focus? Editorial', Drug and Alcohol Review, vol. 31, pp. 363 - 364, http://dx.doi.org/10.1111/j.1465-3362.2012.00450.x/pdf

Mcketin R; Lubman DI, 2011, 'Heavy stimulant use remains a significant health concern for Australia stimulants increase the risks of psychosis and stroke', Medical Journal of Australia, vol. 195, pp. 565 - 566, http://dx.doi.org/10.5694/mja11.11197

McKetin R; Sutherland R; Bright DA; Norberg MM, 2011, 'A systematic review of methamphetamine precursor regulations', Addiction, vol. 106, pp. 1911 - 1924, http://dx.doi.org/10.1111/j.1360-0443.2011.03582.x/full

McKetin R; Lubman DI; Lee NM; Ross JE; Slade TN, 2011, 'Major depression among methamphetamine users entering drug treatment programs', Medical Journal of Australia, vol. 195, pp. S51 - S55, http://www.mja.com.au/public/issues/195_03_010811/mck11008_fm.html

Darke S; Torok M; McKetin R; Kaye SS; Ross JE, 2011, 'Patterns of psychological distress related to regular methamphetamine and opioid use', Addiction Research and Theory, vol. 19, pp. 121 - 127, http://dx.doi.org/10.3109/16066351003695631

Plüddemann A; Flisher AJ; McKetin R; Parry C; Lombard C, 2010, 'Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa', Drug and Alcohol Dependence, vol. 109, pp. 14 - 19, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.021

McKetin R, 2010, 'The Golden Triangle: Inside Southeast Asia's drug trade [book review]', Pacific Affairs, vol. 85, pp. 634 - 635

Darke S; Torok M; Kaye SS; Ross JE; McKetin R, 2010, 'Comparitive rates of violent crime among regular methamphetamine and opioid users: offending and victimization', Addiction, vol. 105, pp. 916 - 919, http://dx.doi.org/10.1111/j.1360-0443.2009.02872.x

Kay-Lambkin F; Baker A; McKetin R; Lee N, 2010, 'Stepping through treatment: Reflections on an adaptive treatment strategy among methamphetamine users with depression', Drug and Alcohol Review, vol. 29, pp. 475 - 482, http://dx.doi.org/10.1111/j.1465-3362.2010.00203.x

Shearer J; Shanahan MD; Darke S; Rodgers CJ; Van Beek IA; McKetin R; Mattick RP, 2010, 'A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence', Drug and Alcohol Review, vol. 29, pp. 235 - 242, http://dx.doi.org/10.1111/j.1465-3362.2009.00148.x

Pluddemann A; Flisher AJ; McKetin R; Parry CD; Lombard CJ, 2010, 'A prospective study of methamphetamine use as a predictor of high school non-attendance in Cape Town, South Africa', Substance Abuse Treatment, Prevention, and Policy, vol. 5, pp. 1 - 7, http://dx.doi.org/10.1186/1747-597X-5-25

McKetin R; Hickey K; Devlin K; Lawrence K, 2010, 'The risk of psychotic symptoms associated with recreational methamphetamine use', Drug and Alcohol Review, vol. 29, pp. 358 - 363, http://dx.doi.org/10.1111/j.1465-3362.2009.00160.x

McKetin R, 2010, 'Methamphetamine addiction: Biological foundations [book review]', Drug and Alcohol Review, vol. 29, pp. 231 - 231, http://dx.doi.org/10.1111/j.1465-3362.2010.00179_5.x

McKetin R; McLaren J; Kelly E, 2009, 'The Validity of Street Terms Used to Monitor the Australian Methamphetamine Market', The Open Addiction Journal, vol. 2, pp. 30 - 33, http://dx.doi.org/10.2174/1874941000902010030

Shearer J; Darke S; Rodgers CJ; Slade T; Van Beek IA; Lewis J; Brady D; McKetin R; Mattick RP; Wodak AD, 2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, vol. 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x

Wallace C; Galloway T; McKetin R; Kelly EV; Leary J, 2009, 'Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia', Drug and Alcohol Review, vol. 28, pp. 592 - 599, http://dx.doi.org/10.1111/j.1465-3362.2008.00016.x

McKetin R; McLaren JA; Kelly EV; Chalmers JJ, 2009, 'The market for crystalline methamphetamine in Sydney, Australia', Global Crime, vol. 10, pp. 113 - 123, http://dx.doi.org/10.1080/17440570902783905

Dawe S; Davis P; Lapworth K; McKetin R, 2009, 'Mechanisms underlying aggressive and hostile behavior in amphetamine users', Current Opinion in Psychiatry, vol. 22, pp. 269 - 273, http://dx.doi.org/10.1097/YCO.0b013e32832a1dd4

McKetin R, 2009, 'The holy grail of supply control: Have we found the evidence?', Addiction, vol. 104, pp. 455 - 456, http://dx.doi.org/10.1111/j.1360-0443.2008.02502.x

Griffiths P; Meacham M; McKetin R, 2008, 'Illicit drug trends globally', International Encyclopedia of Public Health, pp. 515 - 523, http://dx.doi.org/10.1016/B978-012373960-5.00354-3

McKetin R; Kozel N; Vicknasingam B; Lund J, 2008, 'The rise of methamphetamine in southeast and East Asia', Drug and Alcohol Review, vol. 27, pp. 220 - 228, http://dx.doi.org/10.1080/09595230801923710

McKetin R; Ross JE; Kelly EV; Baker A; Lee N; Lubman D; Mattick RP, 2008, 'Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants', Drug and Alcohol Review, vol. 27, pp. 277 - 285, http://dx.doi.org/10.1080/09595230801919486

Kaye SS; Darke S; Duflou J, 2008, 'Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology', Addiction, vol. 103, pp. 1353 - 1360, http://dx.doi.org/10.1111/j.1360-0443.2008.02231.x

Darke S; Kaye SS; McKetin R; Duflou J, 2008, 'Major physical and psychological harms of methamphetamine use', Drug and Alcohol Review, vol. 27, pp. 253 - 262, http://dx.doi.org/10.1080/09595230801923702

McKetin R; Kelly EV; McLaren JA; Proudfoot H, 2008, 'Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use', Drug and Alcohol Review, vol. 27, pp. 482 - 489, http://dx.doi.org/10.1080/09595230801914776

McKetin R; McLaren JA; Lubman D; Hides L, 2008, 'Hostility among methamphetamine users experiencing psychotic symptoms', American Journal on Addictions, vol. 17, pp. 235 - 240, http://dx.doi.org/10.1080/10550490802019816

McKetin R, 2008, 'Methamphetamine precursor regulation: are we controlling or diverting the drug problem?', Addiction, vol. 103, pp. 521 - 523, http://dx.doi.org/10.1111/j.1360-0443.2007.02099.x

Degenhardt LJ; Roxburgh AD; McKetin R, 2007, 'Hospital seperation for cannabis- and methamphetamine-related psycholtic episodes in Australia', Medical Journal of Australia, vol. 186, pp. 342 - 345

Kaye SS; McKetin R; Duflou J; Darke S, 2007, 'Methamphetamine and cardiovascular pathology: a review of the evidence', Addiction, vol. 102, pp. 1204 - 1211, http://dx.doi.org/10.1111/j.1360-0443.2007.01874.x

McKetin R; Kelly EV, 2007, 'Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia', Drug and Alcohol Review, vol. 26, pp. 161 - 168, http://dx.doi.org/10.1080/09595230601146652

McKetin R; Kelly E; McLaren J, 2006, 'The relationship between crystalline methamphetamine use and methamphetamine dependence', Drug and Alcohol Dependence, vol. 85, pp. 198 - 204, http://dx.doi.org/10.1016/j.drugalcdep.2006.04.007

Law MG; Degenhardt LJ; McKetin R, 2006, 'Methods estimating the prevalence of problem drug use', International Journal of Drug Policy, vol. 17, pp. 154 - 158, http://dx.doi.org/10.1016/j.drugpo.2005.02.010

McKetin R; McLaren JA; Lubman D; Hides L, 2006, 'The prevalence of psychotic symptoms among methamphetamine users', Addiction, vol. 101, pp. 1471 - 1478, http://dx.doi.org/10.1111/j.1360-0443.2006.01496.x

Sloboda Z; McKetin R; Kozel NJ, 2005, 'Use of archival data', Epidemiology of Drug Abuse, pp. 63 - 78, http://dx.doi.org/10.1007/0-387-24416-6_5

Griffiths P; McKetin R, 2005, 'A common language for a common problem: The developing role of drug epidemiology in a global context', Epidemiology of Drug Abuse, pp. 161 - 176, http://dx.doi.org/10.1007/0-387-24416-6_11

Gibson AE; Degenhardt LJ; Day CA; McKetin R, 2005, 'Recent trends in heroin supply to markets in Australia, the United States and Western Europe', International Journal of Drug Policy, vol. 16, pp. 293 - 299, http://dx.doi.org/10.1016/j.drugpo.2005.07.001

McKetin R; Kelly EV; Indig D, 2005, 'Characteristics of treatment provided for amphetamine use in New South Wales, Australia', Drug and Alcohol Review, vol. 24, pp. 433 - 436, http://dx.doi.org/10.1080/09595230500290858

Breen CL; Degenhardt LJ; Bruno R; Roxburgh AD; McKetin R, 2004, 'The effects of restricting publicly subsidised temazepamcapsules on benzodiazepine use among injecting drug users in Australia', Medical Journal of Australia, vol. 181, pp. 300 - 304

McKetin R; Griffiths P, 2003, 'Developing a global perspective on drug information systems', Drug and Alcohol Review, vol. 22, pp. 387 - 389, http://dx.doi.org/10.1080/09595230310001613895

Griffiths P; McKetin R, 2003, 'Developing a global perspective on drug consumption patterns and trends- the challenge for drug epidemiology', Bulletin on Narcotics, vol. LV, pp. 1 - 8

Topp LJ; McKetin R, 2003, 'Supporting evidence-based policy-making : a case study of the Illicit Drug Reporting System in Australia', Bulletin on Narcotics, vol. LV,, pp. 23 - 30

Hickman M; Taylor C; Chatterjee A; Degenhardt L; Frischer M; Hay G; Tilling K; Wiessing L; Griffiths P; McKetin R, 2002, 'Estimating the prevalence of problematic drug use: A review of methods and their application', Bulletin on Narcotics, vol. 54, pp. 15 - 32

McKetin R, 2000, 'The illicit drugs reporting system.', N S W Public Health Bull, vol. 11, pp. 49 - 52, http://dx.doi.org/10.1071/nb00025

McKetin R, 1999, 'Use of RAM to monitor illicit drug use in developed countries: can rapid assessment result in a rapid response?', DRUG AND ALCOHOL REVIEW, vol. 18, pp. 333 - 335, http://dx.doi.org/10.1080/09595239996491

McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR, 1999, 'Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans', Neuropsychopharmacology, vol. 21, pp. 380 - 390, http://dx.doi.org/10.1016/S0893-133X(99)00017-2

McKetin R; Solowij N, 1999, 'Event-related potential indices of auditory selective attention in dependent amphetamine users', Biological Psychiatry, vol. 45, pp. 1488 - 1497, http://dx.doi.org/10.1016/S0006-3223(98)00200-5

McKetin R; Mattick RP, 1998, 'Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls', Drug and Alcohol Dependence, vol. 50, pp. 181 - 184, http://dx.doi.org/10.1016/S0376-8716(98)00022-2

McKetin R; Mattick RP, 1997, 'Attention and memory in illicit amphetamine users', Drug and Alcohol Dependence, vol. 48, pp. 235 - 242, http://dx.doi.org/10.1016/S0376-8716(97)00132-4

Conference Papers

Conference Posters

Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Man N; Chrzanowska A; McKetin R; Price O; Gibbs D; Bruno R; Sisson S; Dietze P; Salom C; Degenhardt L; Peacock A, 2020, 'Trends in methamphetamine availability, use, and harms in Australia', presented at The 2020 NDARC Annual Research Symposium, 05 November 2020 - 26 November 2020, https://ndarc.med.unsw.edu.au/resource/trends-methamphetamine-harms-australia

Conference Presentations

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Conference Abstracts

Reports

Theses / Dissertations

McKetin R, 1999, Cognitive functioning and psychological morbidity among illicit amphetamine users

Preprints

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Quinn B; Treloar C; Gray D; Dunlop A; Wilkes E; Ward J, 2019, ‘We Can Do This’: a web-based therapeutic program for reducing methamphetamine use and increasing help-seeking amongst Aboriginal and Torres Strait Islander people: Wait-list control, randomised trial protocol (Preprint), http://dx.doi.org/10.2196/preprints.14084

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young R; Teesson M; Saunders JB, Bidirectional Relationship Between Methamphetamine Use and Positive Psychotic Symptoms in Regular Methamphetamine Users: Evidence From a Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3260803

Find a Person

Quick Links

	Scholarships
	Contact Us